TY - JOUR PY - 2016 DA - 2016// TI - Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31678-6 DO - 10.1016/S0140-6736(16)31678-6 ID - ref1 ER - TY - JOUR AU - Lipton, R. B. AU - Bigal, M. E. AU - Diamond, M. PY - 2007 DA - 2007// TI - Migraine prevalence, disease burden, and the need for preventive therapy JO - Neurology VL - 68 UR - https://doi.org/10.1212/01.wnl.0000252808.97649.21 DO - 10.1212/01.wnl.0000252808.97649.21 ID - Lipton2007 ER - TY - JOUR AU - Buse, D. C. AU - Rupnow, M. F. AU - Lipton, R. B. PY - 2009 DA - 2009// TI - Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life JO - Mayo Clin Proc VL - 84 UR - https://doi.org/10.1016/S0025-6196(11)60561-2 DO - 10.1016/S0025-6196(11)60561-2 ID - Buse2009 ER - TY - JOUR AU - Von Korff, M. AU - Crane, P. AU - Lane, M. PY - 2005 DA - 2005// TI - Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication JO - Pain VL - 113 UR - https://doi.org/10.1016/j.pain.2004.11.010 DO - 10.1016/j.pain.2004.11.010 ID - Von Korff2005 ER - TY - JOUR AU - Ifergane, G. AU - Buskila, D. AU - Simiseshvely, N. AU - Zeev, K. AU - Cohen, H. PY - 2006 DA - 2006// TI - Prevalence of fibromyalgia syndrome in migraine patients JO - Cephalalgia VL - 26 UR - https://doi.org/10.1111/j.1468-2982.2005.01060.x DO - 10.1111/j.1468-2982.2005.01060.x ID - Ifergane2006 ER - TY - JOUR AU - Hagen, K. AU - Einarsen, C. AU - Zwart, J. A. AU - Svebak, S. AU - Bovim, G. PY - 2002 DA - 2002// TI - The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway JO - Eur J Neurol VL - 9 UR - https://doi.org/10.1046/j.1468-1331.2002.00451.x DO - 10.1046/j.1468-1331.2002.00451.x ID - Hagen2002 ER - TY - JOUR AU - Sacco, S. AU - Kurth, T. PY - 2014 DA - 2014// TI - Migraine and the risk for stroke and cardiovascular disease JO - Curr Cardiol Rep VL - 16 UR - https://doi.org/10.1007/s11886-014-0524-1 DO - 10.1007/s11886-014-0524-1 ID - Sacco2014 ER - TY - JOUR AU - Breslau, N. AU - Schultz, L. AU - Lipton, R. AU - Peterson, E. AU - Welch, K. M. PY - 2012 DA - 2012// TI - Migraine headaches and suicide attempt JO - Headache VL - 52 UR - https://doi.org/10.1111/j.1526-4610.2012.02117.x DO - 10.1111/j.1526-4610.2012.02117.x ID - Breslau2012 ER - TY - JOUR AU - Ilgen, M. A. AU - Kleinberg, F. AU - Ignacio, R. V. PY - 2013 DA - 2013// TI - Noncancer pain conditions and risk of suicide JO - JAMA Psychiatry VL - 70 UR - https://doi.org/10.1001/jamapsychiatry.2013.908 DO - 10.1001/jamapsychiatry.2013.908 ID - Ilgen2013 ER - TY - JOUR AU - Evers, S. AU - Áfra, J. AU - Frese, A. PY - 2009 DA - 2009// TI - EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force JO - Eur J Neurol VL - 16 UR - https://doi.org/10.1111/j.1468-1331.2009.02748.x DO - 10.1111/j.1468-1331.2009.02748.x ID - Evers2009 ER - TY - JOUR PY - 2000 DA - 2000// TI - Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review) JO - Neurology VL - 55 UR - https://doi.org/10.1212/WNL.55.6.754 DO - 10.1212/WNL.55.6.754 ID - ref11 ER - TY - JOUR PY - 2012 DA - 2012// TI - A Peer-reviewed supplement to The Canadian Journal of Neurological Sciences JO - Can J Neurol Sci VL - 39 Suppl 2 ID - ref12 ER - TY - JOUR AU - Diamond, S. AU - Bigal, M. E. AU - Silberstein, S. PY - 2007 DA - 2007// TI - Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American migraine prevalence and prevention study JO - Headache VL - 47 ID - Diamond2007 ER - TY - JOUR AU - Silberstein, S. D. PY - 2017 DA - 2017// TI - Topiramate in migraine prevention: a 2016 perspective JO - Headache VL - 57 UR - https://doi.org/10.1111/head.12997 DO - 10.1111/head.12997 ID - Silberstein2017 ER - TY - JOUR AU - Dodick, D. W. PY - 2018 DA - 2018// TI - Migraine JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30478-1 DO - 10.1016/S0140-6736(18)30478-1 ID - Dodick2018 ER - TY - JOUR AU - Silberstein, S. D. AU - Holland, S. AU - Freitag, F. PY - 2012 DA - 2012// TI - Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Report of the quality standards Subcommittee of the American Academy of neurology and the American headache society JO - Neurology VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182535d20 DO - 10.1212/WNL.0b013e3182535d20 ID - Silberstein2012 ER - TY - JOUR AU - Steiner, T. J. AU - Paemeleire, K. AU - Jensen, R. PY - 2007 DA - 2007// TI - European principles of management of common headache disorders in primary care JO - J Headache Pain. VL - 8 ID - Steiner2007 ER - TY - JOUR AU - VanderPluym, J. AU - Evans, R. W. AU - Starling, A. J. PY - 2016 DA - 2016// TI - Long-term use and safety of migraine preventive medications JO - Headache VL - 56 UR - https://doi.org/10.1111/head.12891 DO - 10.1111/head.12891 ID - VanderPluym2016 ER - TY - JOUR AU - Goadsby, P. J. AU - Edvinsson, L. AU - Ekman, R. PY - 1990 DA - 1990// TI - Vasoactive peptide release in the extracerebral circulation of humans during migraine headache JO - Ann Neurol VL - 28 UR - https://doi.org/10.1002/ana.410280213 DO - 10.1002/ana.410280213 ID - Goadsby1990 ER - TY - JOUR AU - Goadsby, P. J. AU - Edvinsson, L. PY - 1993 DA - 1993// TI - The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats JO - Ann Neurol VL - 33 UR - https://doi.org/10.1002/ana.410330109 DO - 10.1002/ana.410330109 ID - Goadsby1993 ER - TY - JOUR AU - Vermeersch, S. AU - Benschop, R. J. AU - Van Hecken, A. PY - 2015 DA - 2015// TI - Translational pharmacodynamics of calcitonin gene-related peptide monoclonal antibody LY2951742 in a capsaicin-induced dermal blood flow model JO - J Pharmacol Exp Ther VL - 354 UR - https://doi.org/10.1124/jpet.115.224212 DO - 10.1124/jpet.115.224212 ID - Vermeersch2015 ER - TY - JOUR AU - Dodick, D. W. AU - Goadsby, P. J. AU - Spierings, E. L. H. PY - 2014 DA - 2014// TI - Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study JO - Lancet Neurol VL - 13 UR - https://doi.org/10.1016/S1474-4422(14)70128-0 DO - 10.1016/S1474-4422(14)70128-0 ID - Dodick2014 ER - TY - JOUR AU - Skljarevski, V. AU - Oakes, T. M. AU - Zhang, Q. PY - 2018 DA - 2018// TI - Effect of different doses of galcanezumab vs placebo for episodic migraine prevention: a randomized clinical trial JO - JAMA Neurol VL - 75 UR - https://doi.org/10.1001/jamaneurol.2017.3859 DO - 10.1001/jamaneurol.2017.3859 ID - Skljarevski2018 ER - TY - JOUR AU - Skljarevski, V. AU - Stauffer, V. L. AU - Zhang, Q. PY - 2017 DA - 2017// TI - Phase 3 Studies (EVOLVE-1 & EVOLVE-2) of Galcanezumab in Episodic Migraine: Results of 6-Month Treatment Phase JO - Cephalalgia VL - 37 Suppl 1 ID - Skljarevski2017 ER - TY - JOUR PY - 2013 DA - 2013// TI - ICHD-3 beta. The International Classification of Headache Disorders, 3rd edition (beta version) JO - Cephalalgia VL - 33 UR - https://doi.org/10.1177/0333102413485658 DO - 10.1177/0333102413485658 ID - ref25 ER - TY - JOUR AU - Posner, K. AU - Brown, G. K. AU - Stanley, B. PY - 2011 DA - 2011// TI - The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults JO - Am J Psychiatry VL - 168 UR - https://doi.org/10.1176/appi.ajp.2011.10111704 DO - 10.1176/appi.ajp.2011.10111704 ID - Posner2011 ER - TY - JOUR AU - Jhingran, P. AU - Osterhaus, J. T. AU - Miller, D. W. AU - Lee, J. T. AU - Kirchdoerfer, L. PY - 1998 DA - 1998// TI - Development and validation of the migraine-specific quality of life questionnaire JO - Headache VL - 38 UR - https://doi.org/10.1046/j.1526-4610.1998.3804295.x DO - 10.1046/j.1526-4610.1998.3804295.x ID - Jhingran1998 ER - TY - JOUR AU - Stewart, W. F. AU - Lipton, R. B. AU - Kolodner, K. AU - Liberman, J. AU - Sawyer, J. PY - 1999 DA - 1999// TI - Reliability of the migraine disability assessment score in a population-based sample of headache sufferers JO - Cephalalgia VL - 19 UR - https://doi.org/10.1046/j.1468-2982.1999.019002107.x DO - 10.1046/j.1468-2982.1999.019002107.x ID - Stewart1999 ER - TY - JOUR AU - Stewart, W. F. AU - Lipton, R. B. AU - Dowson, A. J. AU - Sawyer, J. PY - 2001 DA - 2001// TI - Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability JO - Neurology VL - 56 UR - https://doi.org/10.1212/WNL.56.suppl_1.S20 DO - 10.1212/WNL.56.suppl_1.S20 ID - Stewart2001 ER - TY - STD TI - Guy W. ECDEU assessment manual for psychopharmacology. Rockville: National Institute of Mental Health, Psychopharmacology Research Branch. Revised 1976. p 217 -222. https://archive.org/details/ecdeuassessmentm1933guyw. Accessed 11 May 2018 UR - https://archive.org/details/ecdeuassessmentm1933guyw ID - ref30 ER - TY - JOUR AU - Rendas-Baum, R. AU - Bloudek, L. M. AU - Maglinte, G. A. AU - Varon, S. F. PY - 2013 DA - 2013// TI - The psychometric properties of the migraine-specific quality of life questionnaire version 2.1 (MSQ) in chronic migraine patients JO - Qual Life Res VL - 22 UR - https://doi.org/10.1007/s11136-012-0230-7 DO - 10.1007/s11136-012-0230-7 ID - Rendas-Baum2013 ER - TY - JOUR AU - Lipton, R. B. AU - Stewart, W. F. AU - Sawyer, J. AU - Edmeads, J. G. PY - 2001 DA - 2001// TI - Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire JO - Headache VL - 41 UR - https://doi.org/10.1046/j.1526-4610.2001.01156.x DO - 10.1046/j.1526-4610.2001.01156.x ID - Lipton2001 ER - TY - JOUR AU - Detke, H. C. AU - Wang, S. AU - Skljarevski, V. PY - 2017 DA - 2017// TI - A Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Chronic Migraine: Results from the 3-month Double-Blind Treatment Phase of the REGAIN Study JO - Cephalalgia VL - 37 Suppl 1 ID - Detke2017 ER - TY - JOUR AU - Malessa, R. AU - Gendolla, A. AU - Steinberg, B. PY - 2010 DA - 2010// TI - Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007991003676461 DO - 10.1185/03007991003676461 ID - Malessa2010 ER - TY - JOUR AU - Nelles, G. AU - Schmitt, L. AU - Humbert, T. PY - 2010 DA - 2010// TI - Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting JO - J Headache Pain VL - 11 UR - https://doi.org/10.1007/s10194-009-0163-x DO - 10.1007/s10194-009-0163-x ID - Nelles2010 ER - TY - STD TI - Stauffer VL, Wang S, Bangs, M, et al. Phase-3 safety data from studies comparing galcanezumab and placebo in patients with episodic and chronic migraine. Eur J Neurol. 2018;25(Suppl. 2):298. ID - ref36 ER - TY - JOUR AU - Friedman, L. E. AU - Zhong, Q. Y. AU - Gelaye, B. AU - Williams, M. A. AU - Peterlin, B. L. PY - 2018 DA - 2018// TI - Association between migraine and suicidal behaviors: a nationwide study in the USA JO - Headache VL - 58 UR - https://doi.org/10.1111/head.13235 DO - 10.1111/head.13235 ID - Friedman2018 ER - TY - JOUR AU - Ashina, M. AU - Dodick, D. AU - Goadsby, P. J. PY - 2017 DA - 2017// TI - Erenumab (AMG 334) in episodic migraine: interim analysis of an ongoing open-label study JO - Neurology VL - 89 UR - https://doi.org/10.1212/WNL.0000000000004391 DO - 10.1212/WNL.0000000000004391 ID - Ashina2017 ER - TY - JOUR AU - Dodick, D. W. AU - Turkel, C. C. AU - DeGryse, R. E. PY - 2015 DA - 2015// TI - Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example JO - J Pain VL - 16 UR - https://doi.org/10.1016/j.jpain.2014.11.004 DO - 10.1016/j.jpain.2014.11.004 ID - Dodick2015 ER -